These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15837115)

  • 1. The global alliance for tuberculosis drug development--accomplishments and future directions.
    Gardner CA; Acharya T; Pablos-Méndez A
    Clin Chest Med; 2005 Jun; 26(2):341-7, vii. PubMed ID: 15837115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New horizons of next generation chemotherapy for mycobacteriosis].
    Doi N
    Kekkaku; 2009 Mar; 84(3):133-40. PubMed ID: 19364045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Partnership to Stop TB: a model of an effective public health partnership.
    Kumaresan J; Heitkamp P; Smith I; Billo N
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):120-9. PubMed ID: 14974755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for overcoming tuberculosis: new treatment regimens.
    Freire MC
    World Hosp Health Serv; 2006; 42(1):34-7. PubMed ID: 16669375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to a major disease of poverty: the Global Partnership to Stop TB.
    Lee JW; Loevinsohn E; Kumaresan JA
    Bull World Health Organ; 2002; 80(6):428. PubMed ID: 12131996
    [No Abstract]   [Full Text] [Related]  

  • 9. Fighting tuberculosis: an old disease with new challenges.
    Tripathi RP; Tewari N; Dwivedi N; Tiwari VK
    Med Res Rev; 2005 Jan; 25(1):93-131. PubMed ID: 15389729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Alliance at full steam for new TB drugs.
    Crabb C
    Bull World Health Organ; 2002; 80(6):517. PubMed ID: 12132014
    [No Abstract]   [Full Text] [Related]  

  • 11. An assessment survey of anti-tuberculosis drug management in Cambodia.
    Uchiyama Y; Mao TE; Okada K; Chay S; Kou Soum M; Leng C
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):153-9. PubMed ID: 16499253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with previously treated tuberculosis no longer neglected.
    Zignol M; Wright A; Jaramillo E; Nunn P; Raviglione MC
    Clin Infect Dis; 2007 Jan; 44(1):61-4. PubMed ID: 17143816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tuberculosis: present status and future prospects.
    Onyebujoh P; Zumla A; Ribeiro I; Rustomjee R; Mwaba P; Gomes M; Grange JM
    Bull World Health Organ; 2005 Nov; 83(11):857-65. PubMed ID: 16302043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global epidemiology of tuberculosis: prospects for control.
    Lönnroth K; Raviglione M
    Semin Respir Crit Care Med; 2008 Oct; 29(5):481-91. PubMed ID: 18810682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rising standards for tuberculosis drug development.
    Balganesh TS; Alzari PM; Cole ST
    Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TB Alliance: overcoming challenges to chart the future course of TB drug development.
    Ginsberg A
    Future Med Chem; 2011 Aug; 3(10):1247-52. PubMed ID: 21859299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.